Skin α-synuclein RT-QuIC was reported first by Wang et al. (2020) with sensitivity for PD vs. non-neurodegenerative controls being 94% (44/47) and specificity 98% (42/43) in post-mortem abdominal skin samples. The gene discussed is SNCA; the disease is Parkinson disease.